Data / Drug companies / Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals Co., Ltd.: 8 products in the FDA NDC directory, labeler code 52958
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (labeler code 52958) lists 8 products in the FDA National Drug Code Directory, covering 3 finished drugs by generic name. By type: 4 bulk ingredients, 4 prescription drugs. Its main marketing category is bulk ingredients. The newest product started marketing on December 17, 2025.
The request: Watch Hainan Shuangcheng Pharmaceuticals Co., Ltd. (FDA labeler code 52958): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52958
- Products in commercial distribution
- 8
- Packages
- 8
- Finished drugs by generic name
- 3
- Prescription products
- 4
- Over the counter products
- 0
- Flagged as original packager
- 4 of 4 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- July 31, 2012
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 4 | 50% |
| Generic drugs (ANDA) | 4 | 50% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 4 | 50% |
| Prescription drugs | 4 | 50% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Eptifibatide | 2 | 9 |
| Octreotide acetate | 1 | 11 |
| Bivalirudin | 1 | 13 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 4 | 50% |
| Injection, solution | 3 | 37.5% |
| Injection, powder, lyophilized, for solution | 1 | 12.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Platelet Aggregation Inhibitor | 2 |
| Somatostatin Analog | 1 |
| Anti-coagulant | 1 |
| Direct Thrombin Inhibitor | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Bortezomib | 52958-134 | Powder | Bulk ingredients | December 17, 2025 |
| Octreotide acetate | 52958-117 | Powder | Bulk ingredients | May 2, 2024 |
| Octreotide acetate | 52958-046 | Injection, solution | Generic drugs (ANDA) | May 2, 2024 |
| Eptifibatide | 52958-040 | Injection, solution | Generic drugs (ANDA) | April 21, 2022 |
| Eptifibatide | 52958-402 | Injection, solution | Generic drugs (ANDA) | September 7, 2021 |
| Bivalirudin | 52958-112 | Powder | Bulk ingredients | October 28, 2019 |
| Bivalirudin | 52958-034 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 23, 2019 |
| Eptifibatide | 52958-001 | Powder | Bulk ingredients | July 31, 2012 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.